Association between cytokine polymorphisms and recurrent pregnancy loss: A review of current evidence

Sofoklis Stavros,Periklis Panagopoulos,Nikolaos Machairiotis,Anastasios Potiris,Despoina Mavrogianni,Antonios Sfakianakis,Eirini Drakaki,Chrysi Christodoulaki,Dimitrios Panagiotopoulos,Dimos Sioutis,Theodoros Karampitsakos,Nikolaos Antonakopoulos,Panagiotis Christopoulos,Peter Drakakis
DOI: https://doi.org/10.1002/ijgo.15575
2024-05-07
International Journal of Gynecology & Obstetrics
Abstract:Cytokines are a type of protein that play an important role in the immune response and can also affect many physiological processes in the body. Cytokine polymorphisms refer to genetic variations or mutations that occur within the genes that code for cytokines, which may affect the level of cytokine production and function. Some cytokine polymorphisms have been associated with an increased risk of developing certain diseases, while others may be protective or have no significant effect on health. In recent years, the role of cytokine polymorphisms in the development of recurrent pregnancy loss (RPL) has been studied. RPL or miscarriage is defined as the occurrence of two or more consecutive pregnancy losses before the 20th week of gestation. There are diverse causes leading to RPL, including genetic, anatomical, hormonal, and immunological factors. With regard to cytokine polymorphisms, a few of them have been found to be associated with an increased risk of RPL, for instance, variations in the genes that code for interleukin‐6, tumor necrosis factor‐alpha, and interleukin‐10. The exact mechanisms by which cytokine polymorphisms affect the risk of recurrent miscarriage are still being studied, and further research is essential to fully understand this complex condition. This brief review aims to summarize the recent literature on the association between cytokine polymorphisms and RPL.
obstetrics & gynecology
What problem does this paper attempt to address?